Advertisement
Advertisement

CGEN

CGEN logo

Compugen Ltd

1.84
USD
Sponsored
-0.08
-4.40%
Jan 30, 15:52 UTC -5
Closed
exchange

After-Market

1.89

+0.04
+2.17%

CGEN Earnings Reports

Positive Surprise Ratio

CGEN beat 28 of 39 last estimates.

72%

Next Report

Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.38M
/
$0.05
Implied change from Q3 25 (Revenue/ EPS)
-26.82%
/
-171.43%
Implied change from Q4 24 (Revenue/ EPS)
-5.93%
/
-171.43%

Compugen Ltd earnings per share and revenue

On Nov 10, 2025, CGEN reported earnings of -0.07 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 20.81% surprise. Revenue reached 1.89 million, compared to an expected 1.50 million, with a 26.17% difference. The market reacted with a +3.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 1.38 million USD, implying an decrease of -171.43% EPS, and decrease of -26.82% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Compugen Ltd reported EPS of -$0.07, beating estimates by 20.81%, and revenue of $1.89M, 26.17% above expectations.
The stock price moved up 3.09%, changed from $1.62 before the earnings release to $1.67 the day after.
The next earning report is scheduled for Feb 19, 2026.
Based on 6 analysts, Compugen Ltd is expected to report EPS of $0.05 and revenue of $1.38M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement